CTNM Contineum Therapeutics, Inc.
Healthcare · Market cap: $227.8M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $117.6K |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $94.5K |
| 2026-Q1 | $0 | $532.2K |
| 2026-Q2 | $0 | $961.5K |
| 2026-Q3 | $0 | $270.1K |
| 2026-Q4 | $0 | $0 |
Bought$00 buy days
Sold$2.0M28 sell days
Net insider flow-$2.0Mnet selling · 5 years
Latest trade2026-09-08Stengone Carmine N.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Sell | Stengone Carmine N. | CEO | 2,500 | $16.46 | $41.1K | 1 |
| 2026-08-03 | Sell | Stengone Carmine N. | CEO | 2,500 | $16.01 | $40.0K | 1 |
| 2026-07-09 | Sell | Lorrain Daniel S. | Other C-suite | 25 | $16.00 | $400 | 1 |
| 2026-07-08 | Sell | Stengone Carmine N. | CEO | 2,500 | $16.00 | $40.0K | 1 |
| 2026-07-08 | Sell | Lorrain Daniel S. | Other C-suite | 1,015 | $16.00 | $16.2K | 1 |
| 2026-07-01 | Sell | Lorrain Daniel S. | Other C-suite | 8,353 | $15.84 | $132.3K | 2 |
| 2026-06-30 | Sell | Lorrain Daniel S. | Other C-suite | 28,826 | $16.04 | $462.3K | 1 |
| 2026-06-30 | Sell | Watkins Tim | Other C-suite | 10,833 | $16.02 | $173.6K | 1 |
| 2026-06-30 | Sell | Stengone Carmine N. | CEO | 10,000 | $16.01 | $160.1K | 1 |
| 2026-06-01 | Sell | Lorrain Daniel S. | Other C-suite | 4,170 | $13.16 | $54.9K | 1 |
| 2026-05-01 | Sell | Lorrain Daniel S. | Other C-suite | 4,170 | $13.12 | $54.7K | 2 |
| 2026-04-06 | Sell | Lorrain Daniel S. | Other C-suite | 4,170 | $13.43 | $56.0K | 1 |
| 2026-03-02 | Sell | Lorrain Daniel S. | Other C-suite | 4,170 | $15.01 | $62.6K | 1 |
| 2026-03-02 | Sell | Watkins Tim | Other C-suite | 3,611 | $15.02 | $54.2K | 1 |
| 2026-02-25 | Sell | Lorrain Daniel S. | Other C-suite | 3,824 | $16.01 | $61.2K | 1 |
| 2026-02-25 | Sell | Stengone Carmine N. | CEO | 2,700 | $16.02 | $43.3K | 1 |
| 2026-02-24 | Sell | Stengone Carmine N. | CEO | 4,400 | $16.02 | $70.5K | 1 |
| 2026-02-24 | Sell | Lorrain Daniel S. | Other C-suite | 4,300 | $16.03 | $68.9K | 1 |
| 2026-02-19 | Sell | Lorrain Daniel S. | Other C-suite | 100 | $16.00 | $1.6K | 1 |
| 2026-02-11 | Sell | Lorrain Daniel S. | Other C-suite | 400 | $16.00 | $6.4K | 1 |
| 2026-02-11 | Sell | Stengone Carmine N. | CEO | 400 | $16.00 | $6.4K | 1 |
| 2026-02-03 | Sell | Lorrain Daniel S. | Other C-suite | 4,170 | $14.94 | $62.3K | 2 |
| 2026-01-28 | Sell | Watkins Tim | Other C-suite | 3,611 | $14.18 | $51.2K | 2 |
| 2026-01-05 | Sell | Lorrain Daniel S. | Other C-suite | 4,170 | $10.44 | $43.5K | 2 |
| 2025-12-29 | Sell | Watkins Tim | Other C-suite | 3,611 | $12.06 | $43.5K | 1 |
| 2025-12-23 | Sell | Lorrain Daniel S. | Other C-suite | 4,170 | $12.23 | $51.0K | 1 |
| 2024-11-25 | Sell | Lorrain Daniel S. | Other C-suite | 1,010 | $16.02 | $16.2K | 1 |
| 2024-11-18 | Sell | Lorrain Daniel S. | Other C-suite | 6,190 | $16.38 | $101.4K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Lorrain Daniel S. | Other C-suite | $0 | $1.3M | 2026-07-09 |
| Stengone Carmine N. | CEO | $0 | $401.4K | 2026-09-08 |
| Watkins Tim | Other C-suite | $0 | $322.6K | 2026-06-30 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.